Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By activating these https://elainewrft855933.idblogmaker.com/35322540/tirzepatide-a-promising-new-treatment-for-obesity